DPx to expand facility in North Carolina, add 488 jobs
DPx, the “umbrella name” for Patheon’s three business units specializing in pharmaceutical services, fine chemicals and proprietary products and technologies, will expand operations in Pitt County, N.C. The company plans to create 488 jobs in Greenville, N.C. by the end of 2019 and invest $159 million to increase the site’s capabilities, as well as modernize the site and develop energy efficiency programs at the facility.
The investment also will make the Greenville site home of Patheon’s North American Sterile facility as well as boost growth for its pharmaceutical development services offering, which will be built out at the site.
DPx’s U.S. headquarters is located in Durham, N.C. and the company also has a manufacturing facility in High Point, N.C. The company currently has more than 1,680 employees in North Carolina, including more than 1,000 at its Pitt County facility. Globally the company has over 8,000 employees at more than 20 locations. The expansion will address Patheon’s need for additional manufacturing and development capacity.
Salaries will vary by job function, but the average annual payroll for the new jobs created in the state will be $26.4 million.
The project was made possible in part by an award to Patheon from the state Job Development Investment Grant (JDIG) program, as voted by the state Economic Investment Committee. Receipt of the award is based on proof-of-job creation and other performance requirements. JDIGs are awarded only to new and expanding businesses and industrial projects whose benefits exceed the costs to the state, and which would not be undertaken in North Carolina without the grant.
Patheon is eligible to receive up to 12 annual grants equal to 59% of the state personal income tax withholdings from the eligible new jobs created since the date of the initial award. Receipt of each annual grant is based on state-certified proof that the company has fulfilled incremental job creation requirements. Over 12 years, the JDIG award could yield aggregate benefits to Patheon of more than $6.3 million upon the creation of 488 jobs.